Slide Insurance CEO Entity Sells 532K Shares
Slide Insurance Holdings, Inc. director and CEO Bruce Lucas reported indirect open-market sales of 532,437 shares of common stock from entities he is associated with.
Rhea-AI Filing Summary
Slide Insurance Holdings, Inc. director and CEO Bruce Lucas reported indirect open-market sales of 532,437 shares of common stock from entities he is associated with. IIM Holdings II, LLC sold 172,644 shares on March 5 at $19.37, 241,493 shares on March 6 at $18.59, and 118,300 shares on March 9 at $18.23, all under a Rule 10b5-1 trading plan adopted on November 21, 2025. Footnotes state these LLC-held shares, spouse holdings, and family trusts are beneficially owned indirectly, with Lucas disclaiming beneficial ownership beyond his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 118,300 | $18.23 | $2.16M |
| Sale | Common Stock | 241,493 | $18.59 | $4.49M |
| Sale | Common Stock | 172,644 | $19.37 | $3.34M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (10)
- F1. Sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 21, 2025.
- F2. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $19.11 to $19.67 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F3. The securities reported herein are held by IIM Holdings II, LLC, which is an entity controlled by the Reporting Person. The Reporting Persondisclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F4. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.31 to $19.23 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F5. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $17.65 to $18.54 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F6. Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F7. The amount shown reflects the amount owned by the Reporting Person's spouse after the sale of 52,659 shares of common stock between March 5-9, 2026, pursuant to a 10b5-1 trading plan, at prices ranging from $17.65 to $19.67 per share.
- F8. Represent shares of common stock beneficially owned by the Reporting Person's spouse through Securus Risk Management LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F9. Represent shares held through the Emma Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F10. Represent shares held through the Ava Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did SLDE report for Bruce Lucas?
Were the SLDE insider sales under a Rule 10b5-1 trading plan?
How are spouse and family trust holdings in SLDE treated in this Form 4?
Did the SLDE Form 4 mention additional sales by the CEO’s spouse?
AI-generated analysis. How Rhea-AI works. Not financial advice.